Walleye Capital LLC Chroma Dex Corp. Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
A detailed history of Walleye Capital LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Walleye Capital LLC holds 40,459 shares of CDXC stock, worth $228,188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,459Holding current value
$228,188% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CDXC
# of Institutions
129Shares Held
21.9MCall Options Held
203KPut Options Held
23.9K-
Vanguard Group Inc Valley Forge, PA3.39MShares$19.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$17.6 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.59MShares$14.6 Million5.52% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.31 Million0.14% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.51 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $385M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...